Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Financial Overview
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's market cap is currently €3.86B. The company's EPS TTM is €; its P/E ratio is ―; Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.